Aly Mohammed H, Alshehri Abdulrahman A, Mohammed Abdelgaffar, Almalki Abdulrahman M, Ahmed Walaa A, Almuflihi Alhanouf M, Alwafi Atheer A
Department of Internal Medicine, Security Forces Hospital, Makkah, SAU.
Department of Rheumatology, Security Forces Hospital, Makkah, SAU.
Cureus. 2021 Nov 13;13(11):e19529. doi: 10.7759/cureus.19529. eCollection 2021 Nov.
Vaccine-related erythema nodosum is uncommon, especially after the coronavirus disease 2019 (COVID-19) vaccine. This study presents the first case of the Pfizer vaccine associated with erythema nodosum. A 22-year-old healthy woman presented with a five-day history of several red painful areas with swelling in the lower extremities that started one day after receiving the first dose of Pfizer vaccine. Past medical history, laboratory investigation, and chest radiograph revealed normal results. Erythema nodosum is an immune reaction that manifests as multiple, painful nodules commonly seen on the shin that resolved spontaneously two to eight weeks after the onset. In the absence of laboratory and chest radiograph abnormalities and shortly after receiving the Pfizer vaccine, vaccine-related erythema nodosum is the only possible explanation.
与疫苗相关的结节性红斑并不常见,尤其是在接种2019冠状病毒病(COVID-19)疫苗之后。本研究报告了首例与辉瑞疫苗相关的结节性红斑病例。一名22岁的健康女性在接种第一剂辉瑞疫苗一天后,出现下肢多处红肿疼痛区域并有肿胀,病史长达五天。既往病史、实验室检查及胸部X光检查结果均正常。结节性红斑是一种免疫反应,表现为多个疼痛性结节,常见于胫部,起病后两至八周可自行消退。在没有实验室及胸部X光异常且在接种辉瑞疫苗后不久出现症状的情况下,与疫苗相关的结节性红斑是唯一可能的解释。